Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (IMMX)
CUSIP: 45258H106
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,036,364
- Total 13F shares
- 146,485
- Share change
- -1,371,954
- Total reported value
- $352,000
- Price per share
- $2.39
- Number of holders
- 7
- Value change
- -$5,019,402
- Number of buys
- 6
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 45258H106?
CUSIP 45258H106 identifies IMMX - Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45258H106:
Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vladimir P. Torchilin |
3/4/5
|
Scientific Co-Founder |
—
class O/S missing
|
905,200
|
$4,230,905 | — | 20 Dec 2021 | |
| Murchinson Ltd. |
13F
|
Company |
1.3%
|
695,600
|
$2,476,000 | — | 31 Dec 2021 | |
| Lynwood Capital Management Inc. |
13F
|
Company |
1.1%
|
565,297
|
$2,012,000 | — | 31 Dec 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.23%
|
122,388
|
$436,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
32,649
|
$116,000 | — | 31 Dec 2021 | |
| Eidelman Virant Capital |
13F
|
Company |
0.06%
|
29,856
|
$103,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
26,474
|
$94,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
20,470
|
$73,000 | — | 31 Dec 2021 | |
| PVG ASSET MANAGEMENT CORP |
13F
|
Company |
0.04%
|
20,000
|
$71,200 | — | 31 Dec 2021 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
13,173
|
$47,000 | — | 31 Dec 2021 | |
| Context Capital Management, LLC |
13F
|
Company |
0.02%
|
11,532
|
$41,000 | — | 31 Dec 2021 | |
| CLEAR STREET LLC |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 31 Dec 2021 |
Institutional Holders of Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (IMMX) as of Q1 2022
As of 31 Mar 2022,
Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (IMMX) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
146,485 shares.
The largest 7 holders included
RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, CITADEL ADVISORS LLC, InterOcean Capital Group, LLC, XTX Topco Ltd, BlackRock Inc., and ADVISOR GROUP HOLDINGS, INC..
This page lists
7
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
11
Q1 2022 holders
7
Holder diff
-4
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.